Heparin Cofactor II in Atherosclerotic Lesions From the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

Experimental and Molecular Pathology - United States
doi 10.1016/j.yexmp.2009.09.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Global DNA Methylation and Risk of Subclinical Atherosclerosis in Young Adults: The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

Atherosclerosis
Cardiovascular MedicineCardiology
2011English

Heparin Cofactor II Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Enhancement of Heparin Cofactor II Anticoagulant Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Studies on the Effect of Calcium in Interactions Between Heparin and Heparin Cofactor II Using Surface Plasmon Resonance

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2004English

Glycosaminoglycan-Binding Properties and Kinetic Characterization of Human Heparin Cofactor II Expressed in Escherichia Coli

Analytical Biochemistry
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques

Mediators of Inflammation
ImmunologyCell Biology
2011English

Vaporization of Atherosclerotic Lesions by Photofrin II and Argon Laser

THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE
1987English

Flow Patterns and Preferred Sites of Atherosclerotic Lesions in the Human Aorta – II. Abdominal Aorta

Biorheology
Physiology
2014English

The Significances of Fibrin Deposition in Human Atherosclerotic Lesions

The Journal of Japan Atherosclerosis Society
1977English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy